REQUEST A DEMO
Total
USD $0.00
Search more companies

Medifar Ecza Deposu Ilac A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Medifar Ecza Deposu Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: October 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Medifar Ecza Deposu Ilac A.S. is an enterprise located in Turkiye, with the main office in Istanbul. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on December 26, 1991. Medifar Ecza Deposu Ilac A.S. currently employs 31 (2024) people. In 2021, the company reported a net sales revenue increase of 82.7%. During that time, Medifar Ecza Deposu Ilac A.S.’s total assets grew by 25.97%. The net profit margin of Medifar Ecza Deposu Ilac A.S. increased by 4.3% in 2021.

Headquarters
No:11a Barbaros Mahallesi Yesilcim Sokak Atasehir
Istanbul; Marmara; Postal Code: 34746

Contact Details: Purchase the Medifar Ecza Deposu Ilac A.S. report to view the information.

Website: http://www.medifar.com.tr

Basic Information
Total Employees:
Purchase the Medifar Ecza Deposu Ilac A.S. report to view the information.
Outstanding Shares:
Purchase the Medifar Ecza Deposu Ilac A.S. report to view the information.
Incorporation Date:
December 26, 1991
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Medifar Ecza Deposu Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
82.7%
Total operating revenue
82.7%
Operating profit (EBIT)
25.76%
Net Profit (Loss) for the Period
863.57%
Total assets
25.97%
Total equity
34.7%
Operating Profit Margin (ROS)
-3.69%
Net Profit Margin
4.3%
Return on Equity (ROE)
17.43%
Debt to Equity Ratio
3.74%
Quick Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?